Insulin lispro protamine suspension in intensive insulin treatment: An Italian observational study

Current Medical Research and Opinion

Volumn 25, Issue 9, 2009, Pages 2259-2265

  Citro, Giuseppe ^a   Lorusso, Bruna ^b   Rossi, Andrea ^b   Romaniello, Marianna ^a   Gentilella, Raffaella ^b   Cremasco, Francesco ^b  

^a Poliambulatorio ASL   (Italy)

^b Eli Lilly Italia   (Italy)

Author keywords

Glycaemic control; Hypoglycaemia; Insulin lispro protamine suspension

Indexed keywords

ANTIDIABETIC AGENT; BIGUANIDE DERIVATIVE; CHOLESTEROL; CREATININE; GLICLAZIDE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN LISPRO; ISOPHANE INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; METFORMIN PLUS ROSIGLITAZONE; REPAGLINIDE; TRIACYLGLYCEROL;

ADULT; AGED; ALGORITHM; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; CREATININEMIA; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DIET THERAPY; DRUG DOSE TITRATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; INTENSIVE CARE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; OUTPATIENT DEPARTMENT; PHYSICAL ACTIVITY; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DIABETES MELLITUS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PHARMACEUTICAL SOLUTIONS; PROTAMINES;

EID: 69849104457     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990903166474     Document Type: Article

References (24)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986
2. UKPDS Study Group. UK prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes 1995;44:1249-1258
3. UKPDS Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-865 (Pubitemid 28416719)
4. Tratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-412 (Pubitemid 30609442)
5. American Diabetes Association. Standards of Medical Care in Diabetes - 2009: American Diabetes Association. Diabetes Care 2009;32:S13-61
6. Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes. International Diabetes Federation, 2005. Available at: www.idf.org
7. Jellinger PS, Davidson JA, Blonde L, et al. ACE/AACE Diabetes Road Map Task Force. Road maps to achieve glycemic control in type 2 diabetes mellitus: ACE/AACE Diabetes Road Map Task Force. Endocr Pract 2007;13:260-268
8. Radziuk JR. Neutral Protamine Lispro: activity profile of s.c. administration with and without admixture of soluble lispro. Diabetologia 1996;39:A224
9. DeFelippis MR, Bakaysa DL, Bell MA, et al. Preparation and characterization of a cocrystalline suspension of [LysB28, ProB29]-human insulin analogue. J Pharm Sci 1998;87:170-176 (Pubitemid 28081324)
10. Roach P, Woodworth JR. Clinical pharmacokinetics and pharmacodynamics of insulin lispro mixtures. Clin Pharmacokinet 2002;41:1043-1057 (Pubitemid 35246781)
11. Schwartz S, Zagar AJ, Althouse SK, et al. A single-center, randomized, double-blind, three-way crossover study examining postchallenge glucose responses to human insulin 70/30 and insulin lispro fixed mixtures 75/25 and 50/50 in patients with type 2 diabetes mellitus. Clin Ther 2006;28:1649-1657 (Pubitemid 44838900)
12. Koivisto VA, Tuominen JA, Ebeling P. Lispro Mix25 insulin as premeal therapy in type 2 diabetic patients. Diabetes Care 1999;22:459-462 (Pubitemid 29106905)
13. Roach P, Strack T, Arora V, et al. Improved glycaemic control with the use of self-prepared mixtures of insulin lispro and insulin lispro protamine suspension in patients with types 1 and 2 diabetes. Int J Clin Pract 2001;55:177-182 (Pubitemid 32390155)
14. Roach P, Yue L, Arora V. Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin lispro formulation. Humalog Mix25 Study Group. Diabetes Care 1999;22:1258-1261 (Pubitemid 29350233)
15. Roach P, Trautmann M, Arora V, et al. Improved postprandial blood glucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin lispro-protamine formulations, insulin lispro mix25 and insulin lispro mix50. Mix50 Study Group. Clin Ther 1999;21:523-534 (Pubitemid 29198040)
16. Herz M, Profozic V, Arora V, et al. Effects of a fixed mixture of 25% insulin lispro and 75% NPL on plasma glucose during and after moderate physical exercise in patients with type 2 diabetes. Curr Med Res Opin 2002;18:188-193 (Pubitemid 34886821)
17. Malone JK, Beattie SD, Campaigne BN, et al. Therapy after single oral agent failure: adding a second oral agent or an insulin mixture? Diabetes Res Clin Pract 2003;62:187-195
18. Jacober SJ, Scism-Bacon JL, Zagar AJ. A comparison of intensive mixture therapy with basal insulin therapy in insulin-naïve patients with type 2 diabetes receiving oral antidiabetes agents. Diabetes Obes Metab 2006;8:448-455 (Pubitemid 44349237)
19. Esposito K, Ciotola M, Maiorino MI, et al. Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control. A randomized trial. Ann Intern Med 2008;149:531-539
20. Nathan DM, Buse JB, Davidson MB et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care 2008;31:1-11
21. Citro G, Maioli A, Lo Pomo F, et al. Comparison of dietary intake of type I diabetic patients and nutritional recommendations. Minerva Gastroenterol Dietol 1998;44:141-147
22. Rivellese AA, Boemi M, Cavalot F, et al.; Mind.it Study Group. Dietary habits in type II diabetes mellitus: how is adherence to dietary recommendations? Eur J Clin Nutr 2008;62:660-664 (Pubitemid 351663406)
23. Russell-Jones D, Khan R. Insulin-associated weight gain in diabetes - causes, effects and coping strategies. Diabetes Obes Metab 2007;9:799-812 (Pubitemid 47555203)
24. Malone JK, Bai S, Campaigne BN, et al. Twice-daily pre-mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with type 2 diabetes. Diabet Med 2005;22:374-381 (Pubitemid 40516233)